November 30, 2017 by CDR Blog and Chain Drug Review
Aetna, CVS Health, CVS-Aetna deal
CDR Blog
Speculation about a potential CVS Health acquisition of health insurer Aetna has been mounting over the past month, and now it may have reached a crescendo. Published reports say the companies are in advanced negotiations and that a CVS-Aetna deal could be announced as soon as next week, according to an anonymous source cited in
November 20, 2017 by CDR Blog and Chain Drug Review
antibiotic resistance, antibiotic-resistant bacteria, Be Antibiotics Aware, Centers for Disease Control and Prevention, Gigi Kwik Gronvall, Johns Hopkins Center for Health Security, NACDS, National Association of Chain Drug Stores, Serving the Greater Good: Public Health and Community Pharmacy Partnerships, Steve Anderson, U.S. Antibiotic Awareness Week
CDR Blog
NACDS president and CEO Steve Anderson co-authored an article appearing in Morning Consult that highlights the role of pharmacy in public health. Written with Gigi Kwik Gronvall, senior associate at the Johns Hopkins Center for Health Security, the column explains how community pharmacy is helping to address the threat of anti-microbial resistance as it has
November 15, 2017 by CDR Blog and Chain Drug Review
American College of Cardiology, American Heart Association, high blood pressure, hypertension guidelines, new high blood pressure guidelines, Paul Whelton
CDR Blog
For prescribers and pharmacists, the reduced levels for defining a person as having high blood pressure bring new guidelines for hypertension medication. This week, the American Heart Association and American College of Cardiology announced that high blood pressure is now defined as a systolic reading of 130 mm Hg and higher or a diatolic measure
November 13, 2017 by CDR Blog and Chain Drug Review
digital health, Growing Value of Digital Health, health-related mobile apps, IQVIA Institute for Human Data Science, mobile health apps, mobile health technology, Murray Aitken, wearables
CDR Blog
There’s no slowing down the proliferation of mobile health technology. Currently, consumers can choose from more than 318,500 health-related mobile apps — almost double the number two years ago — and about 200 new apps are launched daily. What’s more, over 340 consumer wearable devices are now on the market globally. And supporting the burgeoning
November 3, 2017 by CDR Blog and Chain Drug Review
Bad for Your Health: Lawsuit Advertising Implications and Solutions, ILR, Jonathan Gavras, Lawsuit ads targeting prescription drugs, Lisa Rickard, opioid crisis, opioid painkillers, Prime Therapeutics, safe disposal of controlled substances, U.S. Chamber Institute for Legal Reform, Xarelto
CDR Blog
Some recently released research uncovered a couple of disconcerting trends concerning prescription drugs. Lawsuit ads targeting prescription drugs and medical devices have caused at least 61 serious medical events, including six deaths, according to a report from the U.S. Chamber Institute for Legal Reform (ILR). This marks an increase from previous reports, ILR said. Titled
October 26, 2017 by CDR Blog and Chain Drug Review
Adam Fein, Amazon, Amazon entering the pharmacy market, Amazon's pharmacy market intentions, CBX, Drug Channels Institute, Greg Lipman, Jeffrey Woldt, pharmacy wholesale licenses, prescription drug business
CDR Blog
Amazon has quietly received approvals for pharmacy wholesale licenses from at least a dozen state pharmacy boards, the St. Louis Post-Dispatch reported Thursday. Those states are Alabama, Arizona, Connecticut, Idaho, Louisiana, Michigan, New Hampshire, New Jersey, Nevada, North Dakota, Oregon and Tennessee. Another pharmacy distribution license application is pending in Maine, the report said. Amazon
October 26, 2017 by CDR Blog and Chain Drug Review
Aetna, Amazon, Brian Tanquilut, CVS Health, CVS-Aetna deal, Jefferies
CDR Blog, Featured Articles, Leading Headlines
Published reports said Thursday that CVS Health is in negotiations to acquire health insurer Aetna. CVS reportedly will offer more than $200 share, or about $66 billion, to purchase the health benefits giant, according to anonymous sources cited by the Wall Street Journal, which originated the story about a potential CVS-Aetna deal. Bloomberg reported that
October 20, 2017 by CDR Blog and Chain Drug Review
drug pricing, NASP, National Association of Specialty Pharmacy, Onco360, pharmacy industry, prescription drug costs, Tom Suozzi
CDR Blog
No one claims to hold “the solution” to soaring costs for prescription drugs and how Americans and payers — including government — can afford to pay for them. But strides toward unraveling the tangle of problems behind this issue won’t be made without determined attempts at substantive discussion between the public and private sectors, according
October 12, 2017 by CDR Blog and Chain Drug Review
Be The First, CATCH Global Foundation, CATCH My Breath, CVS Health, e-cigarettes, Eileen Howard Boone, youth e-cigarette preventio
CDR Blog
CVS Health continues to back up its mantra of getting people “on the path to better health” with action. Having dropped tobacco from its stores and refocused its front end on better-for-you products, CVS is taking aim at e-cigarettes. The company has made a three-year, $500,000 grant to bring the CATCH Global Foundation’s youth e-cigarette
October 3, 2017 by CDR Blog and Chain Drug Review
annual drug costs, annual pharmacy costs, Express Scripts, Glen Stettin, Super Spending: U.S. Trends in High-Cost Medication Use
CDR Blog
There may be a “new normal” for the segment of Americans shouldering astronomical prescription drug costs, a study by Express Scripts reveals. Between 2014 and 2016, the number of people with annual medication costs of $50,000 or more jumped 35%, and in 2016 about three out of every 1,000 people accounted for over 20% of
September 28, 2017 by CDR Blog and Chain Drug Review
Al Babbington, pharmacist on social media, PrescribeWellness, PrescribeWellness 2017 Pharmacy Social Media Survey
CDR Blog
With Americans agog over social media, who do you think they’d like to hear more from? Celebrities? Pro athletes? Presidents? (Actually, we’ve got enough of that one.) For many, it’s pharmacists. The PrescribeWellness 2017 Pharmacy Social Media Survey found that 42% of the 1,000-plus U.S. adults polled want their pharmacist to be more active on
September 25, 2017 by CDR Blog and Chain Drug Review
Madam CJ Walker Beauty Culture, Mary Dennis, New General Market, Nubian Heritage, Nyema Tubman, Richelieu Dennis, SheaMoisture, Sundial Brands
CDR Blog
Liberia-born and -raised Richelieu Dennis, CEO of Sundial Brands Inc., shared the story behind the origins of his skin and hair care company in a recent Q&A with the New York Times. After coming to the U.S. and then graduating from business school Babson College in 1991, Dennis wasn’t able to return to Liberia, which
September 22, 2017 by CDR Blog and Chain Drug Review
Carrie de Moor, Code 3 Emergency Partners, Code 3 Urgent Care & Pharmacy, slideshow, travel health care
CDR Blog, Slideshows
Travel health care products and services have been a popular addition in recent years at both chain and independent drug stores, including those with retail clinics. But another health care operator is going to where the travelers are. Code 3 Emergency Partners LLC, a Frisco, Texas-based privately owned and operated group of over 100 physicians
September 15, 2017 by CDR Blog and Chain Drug Review
ACCAP-Quebec, Canadian Life and Health Insurance Association, CLHIA, Lyne Duhaime, pharmacist fees, pharmacy patients in Quebec, Quebec's more detailed pharmacy invoice
CDR Blog
Pharmacy patients in Quebec now have a better idea of what’s behind pricing when they pick up prescriptions. The province on Sept. 15 began having pharmacies issue a more detailed invoice to provide cost transparency for the drugs dispensed. The new invoice itemizes the pharmacist’s fee, the price of the medication and the wholesaler’s margin.